PPARG and colorectal carcinoma: In addition, many studies in CRC cell lines and animal models have shown that PPARγ activation inhibits cellular proliferation and angiogenesis, promotes differentiation and apoptosis, leading to postulate a putative role for this receptor as a tumor suppressor gene20–24.